North American peripheral neuropathy treatment market is estimated to grow at a CAGR of 4.2% during the forecast period. A significant rise in cancer incidences and increasing prevalence of diabetes are some pivotal factors encouraging market growth. As per the World Health Organization (WHO), in 2018, the number of new cancer incidences reported in North America was nearly 2.4 million. Of these, prostate (18.4%), lung (10.5%), colorectum (7.4%), bladder (5.5%) held the largest share in new cancer incidences in 2018. Growing cancer incidence has led to increasing demand for chemotherapy to destroy rapidly growing cancer cells in the body. However, some chemotherapy drugs may cause peripheral neuropathy, which is resulting in the demand for peripheral neuropathy treatment in which analgesics, antidepressants, or anticonvulsants, as well as topical numbing agents including lidocaine, are often used for the management of pain. Additionally, opioids may be used in cases that involve extreme pain.
North American peripheral neuropathy treatment market is segmented based on type and application. Based on type, the market is classified into antidepressants, pain relievers, antiseizure, and others. Some antidepressants are used to ease nerve pain, even the patient is not depressed. Tricyclic antidepressants may provide relied on mild to moderate nerve pain. Drugs used for this class include desipramine (Norpramin), imipramine (Tofranil), and amitriptyline. Based on the application, the market is classified into diabetes, chemotherapy-induced, and others. As per the Centers for Disease Control and Prevention (CDC), in 2018, 34.2 million Americans, or 10.5% of the US population were suffering from diabetes. Diabetes is the most common form of neuropathic disorders. This, in turn, is supporting the adoption of peripheral neuropathy treatment to manage diabetic peripheral neuropathy.
To Request a Sample of our Report on North American peripheral neuropathy treatment Market: https://www.omrglobal.com/request-sample/north-american-peripheral-neuropathy-treatment-market
North American Peripheral Neuropathy Treatment Market-Segmentation
By Type
- Antidepressants
- Pain Relievers
- Antiseizure
- Others
By Application
- Diabetes
- Chemotherapy-Induced
- Others
A full Report of North American peripheral neuropathy treatment Market is Available at: https://www.omrglobal.com/industry-reports/north-american-peripheral-neuropathy-treatment-market
North American Peripheral Neuropathy Treatment Market– Segment by Country
- US
- Canada
Company Profiles
- Achelios Therapeutics, Inc.
- Acorda Therapeutics, Inc.
- Amneal Pharmaceuticals LLC
- Apotex Inc.
- Assertio Therapeutics, Inc.
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- Grünenthal GmbH
- Innovus Pharmaceuticals, Inc.
- Johnson & Johnson Services Inc.
- Pfizer Inc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-peripheral-neuropathy-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
